Gonçalves Guilherme, Santos Maria Augusta, Frade João Graça, Cunha José Saraiva
Instituto Gulbenkian de Ciência, Oeiras, Portugal.
BMC Public Health. 2007 Jun 12;7:109. doi: 10.1186/1471-2458-7-109.
The need for tetanus toxoid decennial booster doses has been questioned by some experts. Several counter arguments have been presented, supporting the maintenance of decennial adult booster doses with tetanus and diphtheria toxoids (adult formulation of the vaccine: Td). This study aimed to evaluate the use of Td in Portuguese adult women under routine conditions. For that purpose we selected a group of women 30+ years of age to which vaccination was recommended. We intended to know if pre-vaccination antibody concentrations were associated with factors as age at first and last vaccination, number of doses and time since last revaccination. We also intended to assess the serological efficacy of Td booster.
Following the Portuguese guidelines 100 women were vaccinated with Td. Antitetanus toxin IgG (ATT IgG) and antidiphtheria toxin IgG (ADT IgG) levels were measured (mIU/ml) in 100 pre-vaccination and 91 post-vaccination sera. Detailed vaccination records were available from 88 participants.
Twenty-two women (Group A) began vaccination with DPT/DT in their early childhood and their pre-vaccination ATT IgG levels increased with the number of doses received (p = 0.022) and decreased with time since last vaccination (p = 0.016). Among the 66 women who began vaccination in adolescence and adulthood (Group B), with monovalent TT, ATT IgG levels decreased with age at first dose (p < 0.001) and with time since last vaccination (p = 0.041). In Group A, antidiphtheria toxin IgG kinetics was very similar to that observed for ATT IgG. Among women not vaccinated with diphtheria toxoid, ADT IgG levels decreased with age. Serological response to both components of Td was good but more pronounced for ATT IgG.
Our study suggests that, to protect against tetanus, there is no need to administer decennial boosters to the Portuguese adults who have complied with the childhood/adolescent schedule (6 doses of tetanus toxoid). The adult booster intervals could be wider, probably of 20 years. This also seems to apply to protection against diphtheria, but issues on the herd immunity and on the circulation of toxigenic strains need to be better understood.
一些专家对破伤风类毒素十年一次的加强剂量需求提出了质疑。已经提出了一些反驳观点,支持维持成人破伤风和白喉类毒素十年一次的加强剂量(疫苗成人剂型:Td)。本研究旨在评估在常规条件下葡萄牙成年女性中Td的使用情况。为此,我们选择了一组30岁及以上且建议接种疫苗的女性。我们想了解接种前抗体浓度是否与首次和最后一次接种的年龄、接种剂量以及上次复种后的时间等因素相关。我们还打算评估Td加强针的血清学效果。
按照葡萄牙指南,100名女性接种了Td。在100份接种前血清和91份接种后血清中测量了抗破伤风毒素IgG(ATT IgG)和抗白喉毒素IgG(ADT IgG)水平(mIU/ml)。88名参与者有详细的接种记录。
22名女性(A组)在幼儿期开始接种百白破/白破疫苗,她们接种前的ATT IgG水平随接种剂量增加而升高(p = 0.022),随上次接种后的时间延长而降低(p = 0.016)。在66名在青春期和成年期开始接种单价破伤风疫苗的女性中(B组),ATT IgG水平随首次接种年龄增加而降低(p < 0.001),并随上次接种后的时间延长而降低(p = 0.041)。在A组中,抗白喉毒素IgG的动力学与ATT IgG观察到的非常相似。在未接种白喉类毒素的女性中,ADT IgG水平随年龄降低。对Td两种成分的血清学反应良好,但对ATT IgG更为明显。
我们的研究表明,为预防破伤风,对于已按照儿童/青少年接种程序(6剂破伤风类毒素)接种的葡萄牙成年人,无需每十年进行一次加强接种。成人加强接种间隔可以更长,可能为20年。这似乎也适用于预防白喉,但群体免疫和产毒菌株传播方面的问题需要更好地理解。